Biotech company in the market with two concurrent mezzanine offerings

Benson Hill Biosystems, Inc. is in the market with two concurrent mezzanine offerings to raise a total of $2.5 million. The company already placed $451,000 with five investors as part of a funding agreements signed last month. This is the fourth non-brokered placement initiated by the company which raised close to $1 million since its foundation. The company expects to raise additional funds to close the offering within a year and to raise about $7 million overall via a Series A financing round. The company is backed by BioGenerator, a seed fund designed to facilitate the formation of successful, sustainable bioscience companies in the St. Louis region, and Missouri Technology Corp a public-private partnership focusing on Missouri based emerging bioscience companies.

The company focuses on developing and marketing genes encoding trait that boots yield for major crops such as corn, soybeans and rice. According to the company its products are designed for sustainable agriculture to feed an ever growing population and the US bio energy policy.

Benson Hill Biosystems, Inc., headquartered in Cary, NC, was founded in June 2012 by Matthew “Matt” B. Crisp (CEO and President) and Thomas “Tom” P. Brutnell (CSO – Chief Scientist Officer).

Offering recap
Status: First close
Company: Benson Hill Biosystems, Inc.
Industry: Biotechnology
Amount offered: 2,500,000 via two offerings
Amount placed: 451,000


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s